XML 37 R26.htm IDEA: XBRL DOCUMENT v3.20.2
Share-Based Payments (Tables)
9 Months Ended
Sep. 30, 2020
Share-based Payment Arrangement [Abstract]  
Summary of shares available for grant and stock option activity A summary of awards by type and related activity is detailed below.
  Options Outstanding
Shares
Available
For Grant
SharesWeighted-
Average
Exercise
Price
Stock Options:   
Balance at January 1, 2020291,000 — $— 
Exercised— — $— 
Forfeited— — $— 
Expired— — $— 
Stock options granted— — $— 
Balance at September 30, 2020291,000 — $— 
Schedule of activity
 Liability Awards
SARRSUPSU
Other Share/Unit Awards:
Balance at January 1, 2020107,517 14,352 19,108 
Exercised(1,372)(2,357)(4,150)
Forfeited(1,797)(259)— 
Granted— — — 
Balance at September 30, 2020104,348 11,736 14,958 
Summary of information about stock options and SARs outstanding
The following table summarizes information about SARs outstanding at September 30, 2020. There were no options outstanding as of September 30, 2020.

 SARs Outstanding
Number
Outstanding
Weighted-
Average
Remaining
Contractual Life
Number
Exercisable
Exercise prices:   
$132.5619,118 1.2 years19,118 
$210.2223,550 3.2 years19,600 
$216.4811,149 5.4 years11,149 
$311.169,797 6.2 years9,797 
$310.55203 6.6 years203 
$334.349,264 7.0 years6,254 
$303.7711,462 8.0 years3,967 
$252.9119,805 9.1 years249 
Totals104,348  70,337 
   
Aggregate intrinsic value (in thousands)$960  $960 
Summary of assumptions employed using Black-Scholes option pricing model
In estimating the fair value of the SARs outstanding at September 30, 2020 and December 31, 2019, the Company employed the Black-Scholes option pricing model with assumptions detailed below.

September 30,
2020
December 31,
2019
Expected term
1.2 to 9.1 years
1.9 to 10 years
Expected volatility weighted-average32.85 %22.19 %
Expected dividend yield0.20 %0.12 %
Risk-free rate weighted-average0.17 %1.61 %